Rankings
▼
Calendar
OMER FY 2024 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena
OMER
Omeros Corporation
$835M
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$169M
Net Income
-$157M
EPS (Diluted)
$-2.70
Cash Flow
Operating Cash Flow
-$149M
Free Cash Flow
-$149M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$277M
Total Liabilities
$460M
Stockholders' Equity
-$183M
Cash & Equivalents
$3M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$169M
-$165M
-2.9%
Net Income
-$157M
-$118M
-33.1%
← Q4 2023
All Quarters
Q1 2024 →